Study of products counterfeiting protection technologies on the Ukrainian pharmaceutical market

Authors

  • Сергій Володимирович Степаненко National University of Pharmacy 53 Pushkinskaya str., Kharkov, Ukraine, 61002, Ukraine

DOI:

https://doi.org/10.15587/2313-8416.2015.51989

Keywords:

promising areas, holographic technologies, protection of drugs, counterfeiting, thermal indicators, packaging

Abstract

Aim: According to WHO, in recent years, manufacturers of counterfeit medicines have reached such a "skill" that their products are difficult to distinguish from the originals even for health professionals, and the use of such drugs can be dangerous to health and life.

Given that drug forgers endanger the health of people who, not getting the required treatment, are at risk of losing life, protection of medicines is essential in the fight against counterfeiting. The problem of counterfeit medicines is quite relevant for Ukraine. It is known that on the shelves of local pharmacies there is more than 20 % of counterfeit drugs. Particularly acute the problem becomes in times of epidemics (eg seasonal diseases).

Counterfeit drugs might represent a direct danger to life and health of a patient if composed of substandard ingredients or indirectly for those people who take placebos without getting the desired effect.

Methods: Figuring out the importance of packages and labels for a consumer, the use of thermal indicators for monitoring the transportation and storage conditions of drugs.

Results: The most common protection against counterfeiting are holograms envisaged by package layout, developed by the official manufacturer. As for the special protection methods, experts in the future offer to protect packaging with microstickers, radiomarkers, special paints, etc. Ukraine receives additional directions in the fight against substandard and counterfeit medicines in the form of access to the database of Pharmaceutical Inspections of leading countries, but for today in the world there is still no 100% protection against counterfeiting

Conclusions: In the article the significance of labels and packages for a consumer has been revealed; types of counterfeiting that exist in the pharmaceutical market have been listed; the results of research of technologies that protect products from counterfeiting and the use of holograms on the packaging of pharmaceutical products have been reflected; a comparison of falsified drug "No-spa" with original one has been carried out; statistics of drugs that are the most often exposed to falsification has been given; foreign methods of drugs protection have been studied; Application of thermal indicators for monitoring conditions of transportation and storage of drugs has been justified

Author Biography

Сергій Володимирович Степаненко, National University of Pharmacy 53 Pushkinskaya str., Kharkov, Ukraine, 61002

Associate professor, Candidate of Pharm Sciences

Industrial pharmacy department

References

Toporkov, A. A. (2002). Glavnaja zadacha nadzor za farmacevticheskoj dejatel'nost'ju. Farmacevticheskij vestnik, 3, 3.

Nikolaev, A., Odinokov, S. (2004). Sredstvo ot golovnoj boli. Golograficheskie tehnologii – na zashhitu farmpreparatov. Geologija servis. Available at: http://www.holograms.ru/?id=8&pg=1&id1=3

Bulaev, V. M. (2002). Kak udostoverit'sja v kachestve? Farmacevticheskij vestnik, 6 (245), 17.

Toporkov, A. A. (2002). Presech' dejanija fal'sifikatorov. Farmacevticheskij vestnik, 2, 20–21.

Evrokomissija soobshhila o vnedrenii novoj tehnologii bor'by s fal'sifikaciej preparatov (2012). Ezhenedel'nik apteka, 35 (856). Available at: http://www.apteka.ua/article/159419

Samye populjarnye lekarstvennye poddelki (2014). Chernyj spisok. Available at: http://posovesti.com.ua/News.aspx?newsID=1138

Sviridko, S. V., Sobko, A. Ju. (2010). Rol' upakovki i jetiketki v prodvizhenii tovarov. Prometej, 3 (33), 159–162.

Hranenie i transportirovka preparatov v sisteme «holodovoj cepi» (2012). Internet – izdanie industrii krasoty. Available at: http://www.1nep.ru/pro/legislation/explanation/182352/

Alexander, V. B., Barker, K. N. (1986). National survey of hospital pharmacy facilities: Space allocations and functions. Amer. J. hosp. pharm., 43 (2), 324–330.

Counterfeit drugs: Guidelines for the development of measures to combat counterfeit drugs (1999). Department of Essential Drugs and Other Medicines World Health Organization. Geneva: WHO, 61. Available at: http://apps.who.int/medicinedocs/en/d/Jh1456e/

Di Giorgio, D. (2008). Counterfeit medicines: Facts and Practical Advice. IMPACT, 178.

Palmeter, D., Mavroidis, P. C. (2004). Dispute Settlement in the World Trade Organization: Practice and Procedure. Practice and Procedure. Cambridge University Press, 352. doi: 10.1017/cbo9781139177931

Hurwitz, M. A. (1991). Bundling patented drugs and medical services: An antitrust analysis. Columbia Law Review, 91 (5), 1188. doi: 10.2307/1122848

Kohlert, C., Kohlert, M., Chistyakova, T., Ivanov, A., Sadykov, I. (2010). Counterfeit-proofing based on the principle of randomness. Kunststoffe international, 7, 32–35.

Naum, N. B. H. (1997). The ASEAN pharmacenticals project. International conference on National Medicinal Drug Policies, 20, 165–168.

Dillon, S. (2002). International trade and economic law and the EU. Oxford. Portland, Oregon, 400.

Sedlacer, H. et. al (1996). Ways of successful strategies in drug research and development. Weinheim New York: VCH, 252.

Published

2015-10-30

Issue

Section

Pharmaceutical Sciences